The focus in the current work was to examine mRNA expression and breast cancer outcomes, and as a first step we investigated the original research-use PAM50 signature which classified tumors into five distinct subtypes: Luminal A, Luminal B, Basal, Her2-enriched, and normal-like [10]. The gene discussed is ERBB2; the disease is breast carcinoma.